ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Why testosterone boosts hematocrit
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Jerry Brainum" data-source="post: 2634" data-attributes="member: 162"><p><a href="http://biomedgerontology.oxfordjournals.org/content/early/2013/10/24/gerona.glt154.abstract" target="_blank">http://biomedgerontology.oxfordjournals.org/content/early/2013/10/24/gerona.glt154.abstract</a></p><p></p><p><strong>Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point</strong> </p><p><a href="http://biomedgerontology.oxfordjournals.org/search?author1=Eric+Bachman&sortspec=date&submit=Submit" target="_blank">Eric Bachman</a> Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine, Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies, Boston Medical Center, Massachusetts. </p><p> </p><p> </p><p> <strong>Background.</strong> The mechanisms by which testosterone increases hemoglobin and hematocrit remain unclear. </p><p> </p><p> <strong>Methods.</strong> We assessed the hormonal and hematologic responses to testosterone administration in a clinical trial in which older men with mobility limitation were randomized to either placebo or testosterone gel daily for 6 months. </p><p> </p><p> <strong>Results.</strong> The 7%–10% increase in hemoglobin and hematocrit, respectively, with testosterone administration was associated with significantly increased erythropoietin (EPO) levels and decreased ferritin and hepcidin levels at 1 and 3 months. At 6 months, EPO and hepcidin levels returned toward baseline in spite of continued testosterone administration, but EPO levels remained nonsuppressed even though elevated hemoglobin and hematocrit higher than at baseline, suggesting a new set point. Consistent with increased iron utilization, soluble transferrin receptor (sTR) levels and ratio of sTR/log ferritin increased significantly in testosterone-treated men. Hormonal and hematologic responses were similar in anemic participants. The majority of testosterone-treated anemic participants increased their hemoglobin into normal range. </p><p> </p><p> <strong>Conclusions.</strong> Testosterone-induced increase in hemoglobin and hematocrit is associated with stimulation of EPO and reduced ferritin and hepcidin concentrations. We propose that testosterone stimulates erythropoiesis by stimulating EPO and recalibrating the set point of EPO in relation to hemoglobin and by increasing iron utilization for erythropoiesis.</p></blockquote><p></p>
[QUOTE="Jerry Brainum, post: 2634, member: 162"] [URL]http://biomedgerontology.oxfordjournals.org/content/early/2013/10/24/gerona.glt154.abstract[/URL] [B]Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point[/B] [URL='http://biomedgerontology.oxfordjournals.org/search?author1=Eric+Bachman&sortspec=date&submit=Submit']Eric Bachman[/URL] Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine, Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies, Boston Medical Center, Massachusetts. [B]Background.[/B] The mechanisms by which testosterone increases hemoglobin and hematocrit remain unclear. [B]Methods.[/B] We assessed the hormonal and hematologic responses to testosterone administration in a clinical trial in which older men with mobility limitation were randomized to either placebo or testosterone gel daily for 6 months. [B]Results.[/B] The 7%–10% increase in hemoglobin and hematocrit, respectively, with testosterone administration was associated with significantly increased erythropoietin (EPO) levels and decreased ferritin and hepcidin levels at 1 and 3 months. At 6 months, EPO and hepcidin levels returned toward baseline in spite of continued testosterone administration, but EPO levels remained nonsuppressed even though elevated hemoglobin and hematocrit higher than at baseline, suggesting a new set point. Consistent with increased iron utilization, soluble transferrin receptor (sTR) levels and ratio of sTR/log ferritin increased significantly in testosterone-treated men. Hormonal and hematologic responses were similar in anemic participants. The majority of testosterone-treated anemic participants increased their hemoglobin into normal range. [B]Conclusions.[/B] Testosterone-induced increase in hemoglobin and hematocrit is associated with stimulation of EPO and reduced ferritin and hepcidin concentrations. We propose that testosterone stimulates erythropoiesis by stimulating EPO and recalibrating the set point of EPO in relation to hemoglobin and by increasing iron utilization for erythropoiesis. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Why testosterone boosts hematocrit
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top